Advanced search
Start date
Betweenand
Related content
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Potential for stem cell treatment in manganism

Full text
Author(s):
de Moura, Thatiane C. [1] ; Afadlal, Szeifoul [1] ; Hazell, Alan S. [1, 2]
Total Authors: 3
Affiliation:
[1] Univ Estadual Campinas UNICAMP, Programa Fisiopathol, Campinas, SP - Brazil
[2] Univ Montreal, Dept Med, Montreal, PQ - Canada
Total Affiliations: 2
Document type: Journal article
Source: NEUROCHEMISTRY INTERNATIONAL; v. 112, p. 134-145, JAN 2018.
Web of Science Citations: 1
Abstract

Development of manganism (also known as manganese neurotoxicity) is a major complication of manganese exposure in which neurological dysfunction is linked to accumulation of the metal in brain. Due to neuronal cell death in basal ganglia structures, particularly the globus pallidus, functional recovery is limited. Bearing a resemblance to Parkinson's disease, effective treatment for manganism is currently limited. However, the rapidly developing field of stem cell research offers new hope for the treatment of illnesses in which neurodegeneration is a major feature. The first part of this review will focus on the clinical features and pathophysiology of cerebral damage resulting from exposure to manganese, including the role of astrocytes, disruption of energy metabolism, involvement of oxidative stress, excitotoxicity, and inflammation, with the second part exploring how stem cells may provide an important therapeutic strategy for patients with this major neurologic disorder. (C) 2017 Elsevier Ltd. All rights reserved. (AU)

FAPESP's process: 11/02263-3 - Pathophysiology of cerebral glutamate transport dysfunction in acute liver failure
Grantee:Alan Stewart Hazell
Support Opportunities: Regular Research Grants
FAPESP's process: 11/02295-2 - Astrocyte-mediated excitotoxicity in manganism
Grantee:Alan Stewart Hazell
Support Opportunities: Regular Research Grants
FAPESP's process: 13/07559-3 - BRAINN - The Brazilian Institute of Neuroscience and Neurotechnology
Grantee:Fernando Cendes
Support Opportunities: Research Grants - Research, Innovation and Dissemination Centers - RIDC